Why Valeant Pharmaceuticals Stock Tanked 24% This Month (NYSE: VRX)

Valeant Pharmaceuticals stock (NYSE: VRX) is up 5% today (Friday) to $178.49 as the pharmaceutical stock continues its week of extreme volatility. But even with today's gain, VRX stock has dropped 24% in the last month. The recent volatility stems from news the Canadian-based drug company is being investigated by federal prosecutors over its drug […] Here's why this pharmaceutical stock continues to tank... Tags: drug prices , NYSE: VRX , prescription prices , Valeant , Valeant investigation , Valeant Pharmaceuticals Stock , valeant pharmaceuticals stock pricr , Valeant stock , Valeant stock price , VRX stock , VRX stock price To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Why Valeant Pharmaceuticals Stock Tanked 24% This Month (NYSE: VRX) appeared first on Money Morning - We Make Investing Profitable .